サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1402926

家畜用ワクチン市場：世界の産業分析、規模、シェア、成長、動向、予測、2023年～2031年

Livestock Vaccines Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031
出版日: | 発行: Transparency Market Research | ページ情報: 英文 165 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.98円
家畜用ワクチン市場：世界の産業分析、規模、シェア、成長、動向、予測、2023年～2031年
出版日: 2023年11月10日
発行: Transparency Market Research
ページ情報: 英文 165 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

家畜用ワクチン市場- レポートの範囲

世界の家畜用ワクチン市場に関するTMRのレポートは、過去と現在の成長動向、および2023年から2031年の予測期間中に市場の指標の貴重な洞察を得る機会を研究しています。このレポートは、世界の家畜用ワクチン市場の収益を提供します。 2017年から2031年の期間、2023年を基準年、2031年を予測年とみなします。レポートは、2023年から2031年までの世界の家畜用ワクチン市場の複合年間成長率（CAGR %）も提供します。

このレポートは広範な調査を経て作成されました。1次調査では、調査活動の大部分が行われ、アナリストが主要なオピニオンリーダー、業界リーダー、オピニオンメーカーにインタビューを実施しました。2次調査には、家畜用ワクチン市場を理解するために、主要企業の製品文献、年次報告書、プレスリリース、および関連文書の参照が含まれます。

市場スナップショット
2023年の市場価値 54億米ドル
2031年の市場価値 94億米ドル
CAGR 6.4%

このレポートは、世界の家畜用ワクチン市場の競合情勢を詳しく調査しています。世界の家畜用ワクチン市場で活動する主要企業が特定され、それぞれの企業がさまざまな属性の観点からプロファイルされています。会社概要、財務状況、最近の動向、 SWOTは、このレポートで紹介されている世界の家畜用ワクチン市場のプレーヤーの属性です。

目次

第1章 序文

第2章 前提条件と調査手法

第3章 エグゼクティブサマリー：世界市場

第4章 市場概要

  • イントロダクション
  • 概要
  • 市場力学
  • 世界市場の分析と予測、2023～2031年

第5章 重要な洞察

  • 病気の疫学
  • パイプライン分析
  • 主要な業界イベント
  • COVID-19のパンデミックが業界に与える影響

第6章 世界市場の分析と予測：ワクチンの種類別

  • イントロダクションと定義
  • 主な調査結果/発展
  • 市場金額予測：ワクチンの種類別、2023-2031
    • 牛
    • 家禽
    • 豚
    • その他
  • 市場魅力度分析：ワクチンの種類別

第7章 世界市場の分析と予測：技術別

  • イントロダクションと定義
  • 主な調査結果/発展
  • 市場金額予測：技術別、2023-2031
    • 弱毒生ワクチン
    • 不活化ワクチン
    • 組換えワクチン
    • その他
  • 市場魅力度分析：技術別

第8章 世界市場の分析と予測：投与経路別

  • イントロダクションと定義
  • 主な調査結果/発展
  • 市場金額予測：投与経路別、2023-2031
    • 経口
    • 非経口
    • その他
  • 市場魅力度分析：投与経路別

第9章 世界市場の分析と予測：エンドユーザー別

  • イントロダクションと定義
  • 主な調査結果/発展
  • 市場金額予測：エンドユーザー別、2023-2031
    • 動物病院
    • 動物クリニック
    • その他
  • 市場魅力度分析：エンドユーザー別

第10章 世界市場の分析と予測：地域別

  • 主な調査結果
  • 市場金額予測：地域別、2023-2031
    • 北米
    • 欧州
    • アジア太平洋地域
    • ラテンアメリカ
    • 中東・アフリカ
  • 国・地域別の市場魅力度

第11章 北米市場の分析と予測

第12章 欧州市場の分析と予測

第13章 アジア太平洋市場の分析と予測

第14章 ラテンアメリカ市場の分析と予測

第15章 中東・アフリカ市場の分析と予測

第16章 競合情勢

  • 市場プレーヤー-競合マトリックス（企業の階層および規模別）
  • 市場シェア分析：企業別（2022年）
  • 企業プロファイル
    • Dechra Pharmaceuticals PLC
    • Ceva Sante Animale
    • Elanco
    • Merck &Co., Inc.
    • Zoetis Services LLC
    • Boehringer Ingelheim International GmbH.
    • Virbac
    • Biogenesis Bago
    • Ourofino Saude Animal
    • その他
図表

List of Tables

  • Table 01: Global Livestock Vaccines Market Value (US$ Mn) Forecast, by Vaccine Type, 2023-2031
  • Table 02: Global Livestock Vaccines Market Value (US$ Mn) Forecast, by Technology, 2023-2031
  • Table 03: Global Livestock Vaccines Market Value (US$ Mn) Forecast, by Route of Administration, 2023-2031
  • Table 04: Global Livestock Vaccines Market Value (US$ Mn) Forecast, by End-user, 2023-2031
  • Table 05: Global Livestock Vaccines Market Value (US$ Mn) Forecast, by Region, 2023-2031
  • Table 06: North America Livestock Vaccines Market Value (US$ Mn) Forecast, by Country, 2023-2031
  • Table 07: North America Livestock Vaccines Market Value (US$ Mn) Forecast, by Vaccine Type, 2023-2031
  • Table 08: North America Livestock Vaccines Market Value (US$ Mn) Forecast, by Technology, 2023-2031
  • Table 09: North America Livestock Vaccines Market Value (US$ Mn) Forecast, by Route of Administration, 2023-2031
  • Table 10: North America Livestock Vaccines Market Value (US$ Mn) Forecast, by End-user, 2023-2031
  • Table 11: Europe Livestock Vaccines Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023-2031
  • Table 12: Europe Livestock Vaccines Market Value (US$ Mn) Forecast, by Vaccine Type, 2023-2031
  • Table 13: Europe Livestock Vaccines Market Value (US$ Mn) Forecast, by Technology, 2023-2031
  • Table 14: Europe Livestock Vaccines Market Value (US$ Mn) Forecast, by Route of Administration, 2023-2031
  • Table 15: Europe Livestock Vaccines Market Value (US$ Mn) Forecast, by End-user, 2023-2031
  • Table 16: Asia Pacific Livestock Vaccines Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023-2031
  • Table 17: Asia Pacific Livestock Vaccines Market Value (US$ Mn) Forecast, by Vaccine Type, 2023-2031
  • Table 18: Asia Pacific Livestock Vaccines Market Value (US$ Mn) Forecast, by Technology, 2023-2031
  • Table 19: Asia Pacific Livestock Vaccines Market Value (US$ Mn) Forecast, by Route of Administration, 2023-2031
  • Table 20: Asia Pacific Livestock Vaccines Market Value (US$ Mn) Forecast, by End-user, 2023-2031
  • Table 21: Latin America Livestock Vaccines Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023-2031
  • Table 22: Latin America Livestock Vaccines Market Value (US$ Mn) Forecast, by Vaccine Type, 2023-2031
  • Table 23: Latin America Livestock Vaccines Market Value (US$ Mn) Forecast, by Technology, 2023-2031
  • Table 24: Latin America Livestock Vaccines Market Value (US$ Mn) Forecast, by Route of Administration, 2023-2031
  • Table 25: Latin America Livestock Vaccines Market Value (US$ Mn) Forecast, by End-user, 2023-2031
  • Table 26: Middle East & Africa Livestock Vaccines Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023-2031
  • Table 27: Middle East & Africa Livestock Vaccines Market Value (US$ Mn) Forecast, by Vaccine Type, 2023-2031
  • Table 28: Middle East & Africa Livestock Vaccines Market Value (US$ Mn) Forecast, by Technology, 2023-2031
  • Table 29: Middle East & Africa Livestock Vaccines Market Value (US$ Mn) Forecast, by Route of Administration, 2023-2031
  • Table 30: Middle East & Africa Livestock Vaccines Market Value (US$ Mn) Forecast, by End-user, 2023-2031

List of Figures

  • Figure 01: Global Livestock Vaccines Market Value (US$ Mn) Forecast, 2023-2031
  • Figure 02: Global Livestock Vaccines Market Value Share, by Vaccine Type, 2022
  • Figure 03: Livestock Vaccines Market Value Share, by Technology, 2022
  • Figure 04: Livestock Vaccines Market Value Share, by Route of Administration, 2022
  • Figure 05: Global Livestock Vaccines Market Value Share, by End-user, 2022
  • Figure 06: Global Livestock Vaccines Market Value Share Analysis, by Vaccine Type, 2022 and 2031
  • Figure 07: Global Livestock Vaccines Market Attractiveness Analysis, by Vaccine Type, 2023-2031
  • Figure 08: Global Livestock Vaccines Market Revenue (US$ Mn), by Bovine Vaccine , 2023-2031
  • Figure 09: Global Livestock Vaccines Market Revenue (US$ Mn), by Poultry Vaccine, 2023-2031
  • Figure 10: Global Livestock Vaccines Market Revenue (US$ Mn), by Porcine Vaccine, 2023-2031
  • Figure 11: Global Livestock Vaccines Market Revenue (US$ Mn), by Others, 2023-2031
  • Figure 12: Global Livestock Vaccines Market Value Share Analysis, by Technology, 2022 and 2031
  • Figure 13: Global Livestock Vaccines Market Attractiveness Analysis, by Technology 2023-2031
  • Figure 14: Global Livestock Vaccines Market Value (US$ Mn), by Live Attenuated Vaccine, 2023-2031
  • Figure 15: Global Livestock Vaccines Market Value (US$ Mn), by Inactivated Vaccine, 2023-2031
  • Figure 16: Global Livestock Vaccines Market Value (US$ Mn), by Recombinant Vaccine, 2023-2031
  • Figure 17: Global Livestock Vaccines Market Value (US$ Mn), by Others, 2023-2031
  • Figure 18: Global Livestock Vaccines Market Value Share Analysis, by Route of Administration, 2022 and 2031
  • Figure 19: Global Livestock Vaccines Market Attractiveness Analysis, Route of Administration, 2023-2031
  • Figure 20: Global Livestock Vaccines Market Revenue (US$ Mn), by Oral , 2023-2031
  • Figure 21: Global Livestock Vaccines Market Revenue (US$ Mn), by Parenteral, 2023-2031
  • Figure 22: Global Livestock Vaccines Market Revenue (US$ Mn), by Others, 2023-2031
  • Figure 23: Global Livestock Vaccines Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 24: Global Livestock Vaccines Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 25: Global Livestock Vaccines Market Revenue (US$ Mn), by Veterinary Hospitals, 2023-2031
  • Figure 26: Global Livestock Vaccines Market Revenue (US$ Mn), by Veterinary Clinics, 2023-2031
  • Figure 27: Global Livestock Vaccines Market Revenue (US$ Mn), by Others, 2023-2031
  • Figure 28: Global Livestock Vaccines Market Value Share Analysis, by Region, 2022 and 2031
  • Figure 29: Global Livestock Vaccines Market Attractiveness Analysis, by Region, 2023-2031
  • Figure 30: North America Livestock Vaccines Market Value (US$ Mn) Forecast, 2023-2031
  • Figure 31: North America Livestock Vaccines Market Value Share Analysis, by Country, 2022 and 2031
  • Figure 32: North America Livestock Vaccines Market Attractiveness Analysis, by Country, 2023-2031
  • Figure 33: North America Livestock Vaccines Market Value Share Analysis, by Vaccine Type, 2022 and 2031
  • Figure 34: North America Livestock Vaccines Market Attractiveness Analysis, by Vaccine Type, 2023-2031
  • Figure 35: North America Livestock Vaccines Market Value Share Analysis, by Technology, 2022 and 2031
  • Figure 36: North America Livestock Vaccines Market Attractiveness Analysis, by Technology 2023-2031
  • Figure 37: North America Livestock Vaccines Market Value Share Analysis, by Route of Administration, 2022 and 2031
  • Figure 38: North America Livestock Vaccines Market Attractiveness Analysis, Route of Administration, 2023-2031
  • Figure 39: North America Livestock Vaccines Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 40: North America Livestock Vaccines Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 41: Europe Livestock Vaccines Market Value (US$ Mn) Forecast, 2023-2031
  • Figure 42: Europe Livestock Vaccines Market Value Share Analysis, by Country, 2022 and 2031
  • Figure 43: Europe Livestock Vaccines Market Attractiveness Analysis, by Country, 2023-2031
  • Figure 44: Europe Livestock Vaccines Market Value Share Analysis, by Vaccine Type, 2022 and 2031
  • Figure 45: Europe Livestock Vaccines Market Attractiveness Analysis, by Vaccine Type, 2023-2031
  • Figure 46: Europe Livestock Vaccines Market Value Share Analysis, by Technology, 2022 and 2031
  • Figure 47: Europe Livestock Vaccines Market Attractiveness Analysis, by Technology 2023-2031
  • Figure 48: Europe Livestock Vaccines Market Value Share Analysis, by Route of Administration, 2022 and 2031
  • Figure 49: Europe Livestock Vaccines Market Attractiveness Analysis, Route of Administration, 2023-2031
  • Figure 50: Europe Livestock Vaccines Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 51: Europe Livestock Vaccines Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 52: Asia Pacific Livestock Vaccines Market Value (US$ Mn) Forecast, 2023-2031
  • Figure 53: Asia Pacific Livestock Vaccines Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 54: Asia Pacific Livestock Vaccines Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 55: Asia Pacific Livestock Vaccines Market Value Share Analysis, by Vaccine Type, 2022 and 2031
  • Figure 56: Asia Pacific Livestock Vaccines Market Attractiveness Analysis, by Vaccine Type, 2023-2031
  • Figure 57: Asia Pacific Livestock Vaccines Market Value Share Analysis, by Technology, 2022 and 2031
  • Figure 58: Asia Pacific Livestock Vaccines Market Attractiveness Analysis, by Technology 2023-2031
  • Figure 59: Asia Pacific Livestock Vaccines Market Value Share Analysis, by Route of Administration, 2022 and 2031
  • Figure 60: Asia Pacific Livestock Vaccines Market Attractiveness Analysis, Route of Administration, 2023-2031
  • Figure 61: Asia Pacific Livestock Vaccines Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 62: Asia Pacific Livestock Vaccines Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 63: Latin America Livestock Vaccines Market Value (US$ Mn) Forecast, 2023-2031
  • Figure 64: Latin America Livestock Vaccines Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 65: Latin America Livestock Vaccines Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 66: Latin America Livestock Vaccines Market Value Share Analysis, by Vaccine Type, 2022 and 2031
  • Figure 67: Latin America Livestock Vaccines Market Attractiveness Analysis, by Vaccine Type, 2023-2031
  • Figure 68: Latin America Livestock Vaccines Market Value Share Analysis, by Technology, 2022 and 2031
  • Figure 69: Latin America Livestock Vaccines Market Attractiveness Analysis, by Technology, 2023-2031
  • Figure 70: Latin America Livestock Vaccines Market Value Share Analysis, by Route of Administration, 2022 and 2031
  • Figure 71: Latin America Livestock Vaccines Market Attractiveness Analysis, Route of Administration, 2023-2031
  • Figure 72: Latin America Livestock Vaccines Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 73: Latin America Livestock Vaccines Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 74: Middle East & Africa Livestock Vaccines Market Value (US$ Mn) Forecast, 2023-2031
  • Figure 75: Middle East & Africa Livestock Vaccines Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 76: Middle East & Africa Livestock Vaccines Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 77: Middle East & Africa Livestock Vaccines Market Value Share Analysis, by Vaccine Type, 2022 and 2031
  • Figure 78: Middle East & Africa Livestock Vaccines Market Attractiveness Analysis, by Vaccine Type, 2023-2031
  • Figure 79: Middle East & Africa Livestock Vaccines Market Value Share Analysis, by Technology, 2022 and 2031
  • Figure 80: Middle East & Africa Livestock Vaccines Market Attractiveness Analysis, by Technology 2023-2031
  • Figure 81: Middle East & Africa Livestock Vaccines Market Value Share Analysis, by Route of Administration, 2022 and 2031
  • Figure 82: Middle East & Africa Livestock Vaccines Market Attractiveness Analysis, by Route of Administration, 2023-2031
  • Figure 83: Middle East & Africa Livestock Vaccines Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 84: Middle East & Africa Livestock Vaccines Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 85: Global Livestock Vaccines Market Share Analysis By Company (2022)
目次
Product Code: TMRGL85857

Livestock Vaccines Market - Scope of Report

TMR's report on the global livestock vaccines market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global livestock vaccines market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global livestock vaccines market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the livestock vaccines market.

Market Snapshot
Market Value in 2023US$ 5.4 Bn
Market Value in 2031US$ 9.4 Bn
CAGR6.4%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global livestock vaccines market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global livestock vaccines market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global livestock vaccines market.

The report delves into the competitive landscape of the global livestock vaccines market. Key players operating in the global livestock vaccines market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global livestock vaccines market profiled in this report.

Key Questions Answered in Global livestock vaccines Market Report:

  • What is the sales/revenue generated by livestock vaccines across all regions during the forecast period?
  • What are the opportunities in the global livestock vaccines market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Livestock Vaccines Market - Research Objectives and Research Approach

The comprehensive report on the global livestock vaccines market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global livestock vaccines market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global livestock vaccines market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Livestock Vaccines Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Segment Definition
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Livestock Vaccines Market Analysis and Forecast, 2023-2031

5. Key Insights

  • 5.1. Disease Epidemiology
  • 5.2. Pipeline Analysis
  • 5.3. Key Industry Events
  • 5.4. COVID-19 Pandemic Impact on Industry

6. Global Livestock Vaccines Market Analysis and Forecast, by Vaccine Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Vaccine Type, 2023-2031
    • 6.3.1. Bovine Vaccine
    • 6.3.2. Poultry Vaccine
    • 6.3.3. Porcine Vaccine
    • 6.3.4. Others
  • 6.4. Market Attractiveness Analysis, by Vaccine Type

7. Global Livestock Vaccines Market Analysis and Forecast, by Technology

  • 7.1. Introduction & Definition
  • 7.2. Key Findings/Developments
  • 7.3. Market Value Forecast, by Technology, 2023-2031
    • 7.3.1. Live Attenuated Vaccine
    • 7.3.2. Inactivated Vaccine
    • 7.3.3. Recombinant Vaccine
    • 7.3.4. Others
  • 7.4. Market Attractiveness Analysis, by Technology

8. Global Livestock Vaccines Market Analysis and Forecasts, by Route of Administration

  • 8.1. Introduction & Definition
  • 8.2. Key Findings/Developments
  • 8.3. Market Value Forecast, by Route of Administration, 2023-2031
    • 8.3.1. Oral
    • 8.3.2. Parenteral
    • 8.3.3. Others
  • 8.4. Market Attractiveness Analysis, by Route of Administration

9. Global Livestock Vaccines Market Analysis and Forecast, by End-user

  • 9.1. Introduction & Definition
  • 9.2. Key Findings/Developments
  • 9.3. Market Value Forecast, by End-user, 2023-2031
    • 9.3.1. Veterinary Hospitals
    • 9.3.2. Veterinary Clinics
    • 9.3.3. Others
  • 9.4. Market Attractiveness Analysis, by End-user

10. Global Livestock Vaccines Market Analysis and Forecast, by Region

  • 10.1. Key Findings
  • 10.2. Market Value Forecast, by Region, 2023-2031
    • 10.2.1. North America
    • 10.2.2. Europe
    • 10.2.3. Asia Pacific
    • 10.2.4. Latin America
    • 10.2.5. Middle East & Africa
  • 10.3. Market Attractiveness By Country/Region

11. North America Livestock Vaccines Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Vaccine Type, 2023-2031
    • 11.2.1. Bovine Vaccine
    • 11.2.2. Poultry Vaccine
    • 11.2.3. Poultry Vaccine
    • 11.2.4. Others
  • 11.3. Market Value Forecast, by Technology, 2023-2031
    • 11.3.1. Live Attenuated Vaccine
    • 11.3.2. Inactivated Vaccine
    • 11.3.3. Recombinant Vaccine
    • 11.3.4. Others
  • 11.4. Market Value Forecast, by Route of Administration, 2023-2031
    • 11.4.1. Oral
    • 11.4.2. Parenteral
    • 11.4.3. Others
  • 11.5. Market Value Forecast, by End-user, 2023-2031
    • 11.5.1. Veterinary Hospitals
    • 11.5.2. Veterinary Clinics
    • 11.5.3. Others
  • 11.6. Market Value Forecast, by Country, 2023-2031
    • 11.6.1. U.S.
    • 11.6.2. Canada
  • 11.7. Market Attractiveness Analysis
    • 11.7.1. By Vaccine Type
    • 11.7.2. By Technology
    • 11.7.3. By Route of Administration
    • 11.7.4. By End-user
    • 11.7.5. By Country/Sub-region

12. Europe Livestock Vaccines Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Vaccine Type, 2023-2031
    • 12.2.1. Bovine Vaccine
    • 12.2.2. Poultry Vaccine
    • 12.2.3. Porcine Vaccine
    • 12.2.4. Others
  • 12.3. Market Value Forecast, by Technology, 2023-2031
    • 12.3.1. Live Attenuated Vaccine
    • 12.3.2. Inactivated Vaccine
    • 12.3.3. Recombinant Vaccine
    • 12.3.4. Others
  • 12.4. Market Value Forecast, by Route of Administration, 2023-2031
    • 12.4.1. Oral
    • 12.4.2. Parenteral
    • 12.4.3. Others
  • 12.5. Market Value Forecast, by End-user, 2023-2031
    • 12.5.1. Veterinary Hospitals
    • 12.5.2. Veterinary Clinics
    • 12.5.3. Others
  • 12.6. Market Value Forecast, by Country/Sub-region, 2023-2031
    • 12.6.1. Germany
    • 12.6.2. U.K.
    • 12.6.3. France
    • 12.6.4. Italy
    • 12.6.5. Spain
    • 12.6.6. Rest of Europe
  • 12.7. Market Attractiveness Analysis
    • 12.7.1. By Vaccine Type
    • 12.7.2. By Technology
    • 12.7.3. By Route of Administration
    • 12.7.4. By End-user
    • 12.7.5. By Country/Sub-region

13. Asia Pacific Livestock Vaccines Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Vaccine Type, 2023-2031
    • 13.2.1. Bovine Vaccine
    • 13.2.2. Poultry Vaccine
    • 13.2.3. Porcine Vaccine
    • 13.2.4. others
  • 13.3. Market Value Forecast, by Technology, 2023-2031
    • 13.3.1. Live Attenuated Vaccine
    • 13.3.2. Inactivated Vaccine
    • 13.3.3. Recombinant Vaccine
    • 13.3.4. Others
  • 13.4. Market Value Forecast, by Route of Administration, 2023-2031
    • 13.4.1. Oral
    • 13.4.2. Parenteral
    • 13.4.3. Others
  • 13.5. Market Value Forecast, by End-user, 2023-2031
    • 13.5.1. Veterinary Hospitals
    • 13.5.2. Veterinary Clinics
    • 13.5.3. Others
  • 13.6. Market Value Forecast, by Country/Sub-region, 2023-2031
    • 13.6.1. China
    • 13.6.2. Japan
    • 13.6.3. India
    • 13.6.4. Australia & New Zealand
    • 13.6.5. Rest of Asia Pacific
  • 13.7. Market Attractiveness Analysis
    • 13.7.1. By Vaccine Type
    • 13.7.2. By Technology
    • 13.7.3. By Route of Administration
    • 13.7.4. By End-user
    • 13.7.5. By Country/Sub-region

14. Latin America Livestock Vaccines Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast, by Vaccine Type, 2023-2031
    • 14.2.1. Bovine Vaccine
    • 14.2.2. Poultry Vaccine
    • 14.2.3. Porcine Vaccine
    • 14.2.4. Others Vaccine
  • 14.3. Market Value Forecast, by Technology, 2023-2031
    • 14.3.1. Live Attenuated Vaccine
    • 14.3.2. Inactivated Vaccine
    • 14.3.3. Recombinant Vaccine
    • 14.3.4. Others
  • 14.4. Market Value Forecast, by Route of Administration, 2023-2031
    • 14.4.1. Oral
    • 14.4.2. Parenteral
    • 14.4.3. Others
  • 14.5. Market Value Forecast, by End-user, 2023-2031
    • 14.5.1. Veterinary Hospitals
    • 14.5.2. Veterinary Clinics
    • 14.5.3. Others
  • 14.6. Market Value Forecast, by Country/Sub-region, 2023-2031
    • 14.6.1. Brazil
    • 14.6.2. Mexico
    • 14.6.3. Rest of Latin America
  • 14.7. Market Attractiveness Analysis
    • 14.7.1. By Vaccine Type
    • 14.7.2. By Technology
    • 14.7.3. By Route of Administration
    • 14.7.4. By End-user
    • 14.7.5. By Country/Sub-region

15. Middle East & Africa Livestock Vaccines Market Analysis and Forecast

  • 15.1. Introduction
    • 15.1.1. Key Findings
  • 15.2. Market Value Forecast, by Vaccine Type, 2023-2031
    • 15.2.1. Bovine Vaccine
    • 15.2.2. Poultry Vaccine
    • 15.2.3. Porcine Vaccine
    • 15.2.4. Others
  • 15.3. Market Value Forecast, by Technology, 2023-2031
    • 15.3.1. Live Attenuated Vaccine
    • 15.3.2. Inactivated Vaccine
    • 15.3.3. Recombinant Vaccine
    • 15.3.4. Others
  • 15.4. Market Value Forecast, by Route of Administration, 2023-2031
    • 15.4.1. Oral
    • 15.4.2. Parenteral
    • 15.4.3. Others
  • 15.5. Market Value Forecast, by End-user, 2023-2031
    • 15.5.1. Veterinary Hospitals
    • 15.5.2. Veterinary Clinics
    • 15.5.3. Others
  • 15.6. Market Value Forecast, by Country/Sub-region, 2023-2031
    • 15.6.1. GCC Countries
    • 15.6.2. South Africa
    • 15.6.3. Rest of Middle East & Africa
  • 15.7. Market Attractiveness Analysis
    • 15.7.1. By Vaccine Type
    • 15.7.2. By Technology
    • 15.7.3. By Route of Administration
    • 15.7.4. By End-user
    • 15.7.5. By Country/Sub-region

16. Competition Landscape

  • 16.1. Market Player - Competition Matrix (By Tier and Size of Companies)
  • 16.2. Market Share Analysis, by Company (2022)
  • 16.3. Company Profiles
    • 16.3.1. Dechra Pharmaceuticals PLC
      • 16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.1.2. Product Portfolio
      • 16.3.1.3. Financial Overview
      • 16.3.1.4. SWOT Analysis
      • 16.3.1.5. Strategic Overview
    • 16.3.2. Ceva Sante Animale
      • 16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.2.2. Product Portfolio
      • 16.3.2.3. Financial Overview
      • 16.3.2.4. SWOT Analysis
      • 16.3.2.5. Strategic Overview
    • 16.3.3. Elanco
      • 16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.3.2. Product Portfolio
      • 16.3.3.3. Financial Overview
      • 16.3.3.4. SWOT Analysis
      • 16.3.3.5. Strategic Overview
    • 16.3.4. Merck & Co., Inc.
      • 16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.4.2. Product Portfolio
      • 16.3.4.3. Financial Overview
      • 16.3.4.4. SWOT Analysis
      • 16.3.4.5. Strategic Overview
    • 16.3.5. Zoetis Services LLC
      • 16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.5.2. Product Portfolio
      • 16.3.5.3. Financial Overview
      • 16.3.5.4. SWOT Analysis
      • 16.3.5.5. Strategic Overview
    • 16.3.6. Boehringer Ingelheim International GmbH.
      • 16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.6.2. Product Portfolio
      • 16.3.6.3. Financial Overview
      • 16.3.6.4. SWOT Analysis
      • 16.3.6.5. Strategic Overview
    • 16.3.7. Virbac
      • 16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.7.2. Product Portfolio
      • 16.3.7.3. Financial Overview
      • 16.3.7.4. SWOT Analysis
      • 16.3.7.5. Strategic Overview
    • 16.3.8. Biogenesis Bago
      • 16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.8.2. Product Portfolio
      • 16.3.8.3. Financial Overview
      • 16.3.8.4. SWOT Analysis
      • 16.3.8.5. Strategic Overview
    • 16.3.9. Ourofino Saude Animal
      • 16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.9.2. Product Portfolio
      • 16.3.9.3. Financial Overview
      • 16.3.9.4. SWOT Analysis
      • 16.3.9.5. Strategic Overview
    • 16.3.10. VETAL Animal Health Products, Inc.
      • 16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.10.2. Product Portfolio
      • 16.3.10.3. Financial Overview
      • 16.3.10.4. SWOT Analysis
      • 16.3.10.5. Strategic Overview
    • 16.3.11. Other prominent Players
      • 16.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.11.2. Product Portfolio
      • 16.3.11.3. Financial Overview
      • 16.3.11.4. SWOT Analysis
      • 16.3.11.5. Strategic Overview